BTC $78,515.74 -0.78%
ETH $2,489.84 -0.10%
BNB $752.45 +1.59%
XRP $1.43 +2.14%
SOL $103.78 -0.38%
TRX $0.3389 +1.45%
DOGE $0.0900 -0.31%
ADA $0.2237 +1.01%
BCH $257.43 -1.24%
LINK $12.68 -2.08%
HYPE $83.88 -1.61%
AAVE $129.11 -2.57%
SUI $0.8205 +0.19%
XLM $0.1902 -0.80%
ZEC $1,177.18 +0.87%
BTC $78,515.74 -0.78%
ETH $2,489.84 -0.10%
BNB $752.45 +1.59%
XRP $1.43 +2.14%
SOL $103.78 -0.38%
TRX $0.3389 +1.45%
DOGE $0.0900 -0.31%
ADA $0.2237 +1.01%
BCH $257.43 -1.24%
LINK $12.68 -2.08%
HYPE $83.88 -1.61%
AAVE $129.11 -2.57%
SUI $0.8205 +0.19%
XLM $0.1902 -0.80%
ZEC $1,177.18 +0.87%

Public company Leap Therapeutics completes $58,888,888 private placement to initiate digital asset financial strategy

2025-10-09 19:13:53

ChainCatcher news, biotechnology company Leap Therapeutics (NASDAQ: LPTX) announced that it has completed the previously announced private placement led by Winklevoss Capital, raising $58,888,888 in cash to initiate its digital asset financial strategy.

Winklevoss Capital will provide funding and strategic support to help Leap build and execute its digital asset financial strategy.

app_icon
ChainCatcher Building the Web3 world with innovations.